Transgene S.A.
TNG.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €79,334 | €139,043 | €164,974 | €231,424 |
| - Cash | €16,670 | €15,666 | €4,403 | €5,911 |
| + Debt | €10,396 | €1,257 | €2,449 | €3,844 |
| Enterprise Value | €73,060 | €124,634 | €163,020 | €229,357 |
| Revenue | €6,353 | €7,900 | €3,126 | €9,993 |
| % Growth | -19.6% | 152.7% | -68.7% | – |
| Gross Profit | -€27,925 | -€21,688 | -€29,042 | -€22,890 |
| % Margin | -439.6% | -274.5% | -929% | -229.1% |
| EBITDA | -€26,652 | -€28,440 | -€30,327 | -€23,550 |
| % Margin | -419.5% | -360% | -970.2% | -235.7% |
| Net Income | -€33,971 | -€22,328 | -€32,810 | -€20,004 |
| % Margin | -534.7% | -282.6% | -1,049.6% | -200.2% |
| EPS Diluted | -0.29 | -0.22 | -0.33 | -0.22 |
| % Growth | -31.8% | 33.3% | -50% | – |
| Operating Cash Flow | -€23,548 | -€34,671 | -€20,303 | -€31,943 |
| Capital Expenditures | -€3,066 | -€2,667 | -€1,535 | -€686 |
| Free Cash Flow | -€26,623 | -€37,417 | -€21,838 | -€32,629 |